Lead, RBC Leishmania Antibody, IgG (Visceral Leishmaniasis) Lead, Urine Leptin, Quantitative by Chemiluminescent Immunoassay LEB Antigen Typing – Patient Leptospira Antibody, IgM by Dot Blot Lecithin-Sphingomyelin Ratio (Inactive as of 11/14/16) Leptospira Culture Leflunomide Metabolite, Serum or Plasma Leucine Aminopeptidase (LAP), Serum Legionella pneumophila Antibody (Type 1), IgG by IFA Leucine-Rich, Glioma-Inactivated Protein 1 Antibody, IgG and Contactin-Associated Protein-2 Antibody, IgG with Reflex to Titers Lipid Panel, Extended Liver-Kidney Microsome Antibody, IgG LipoProfile by Nuclear Magnetic Resonance (NMR) LMNA-Related Disorders (LMNA) Deletion/Duplication LipoProfile by Nuclear Magnetic Resonance (NMR), Particle Analysis Only LMNA-Related Disorders (LMNA) Sequencing Lipoprotein (a) Loeys-Dietz Syndrome (TGFBR1 and TGFBR2) Sequencing
